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ABSTRACT
Hepatitis B virus (HBV) infection is a serious global health problem. HBV has a high 
viral genetic diversity, with 10 genotypes recognized. In Brazil, the Roraima State is the third 
in the Northern region regarding the number of hepatitis B cases. On the other hand, few data 
on HBV genotyping and phylogenetic analysis are available. The purpose of this study is to 
characterize the HBV genotypes circulating in Roraima State. Of the 113 chronic hepatitis 
B patients enrolled in this study, 40 were HBV-DNA positive. A fragment of 280 bp (S gene) 
was amplified by PCR and submitted to nucleotide sequencing. A dataset containing the viral 
sequences obtained in this study, plus 130 obtained from GenBank was used for genotyping 
by phylogenetic analysis. The HBV subgenotype distribution found was A1 (62.5%), A2 
(7.5%), D2, D3, D4 (2.5%), F2a (12.5%), and F3 (10%). We characterized the genotypes 
and subgenotypes of HBV circulating among patients in the State of Roraima. In addition, 
our study shows for the first time the HBV/F3 genotype circulating in Brazil. In conclusion, 
our findings showed a high diversity of HBV genotypes in Roraima, which is also found in 
other Brazilian geographical regions.
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INTRODUCTION
Hepatitis B virus (HBV) evolution is driven by a high mutation rate during 
replication, estimated to be 1.4-3.2 x 10-5 nucleotide substitutions per site per 
year, which is more than 10-fold higher than other DNA viruses1. This leads to 
a high degree of genetic heterogeneity, resulting in ten genotypes (A to J) which 
have distinct geographical distribution. HBV genotypes are characterized by a 
difference in the nucleotide sequences of 8% or more, whereas differences between 
4 to 8% are classified as subgenotypes2. Indeed, most genotypes are now divided 
into subgenotypes with distinct virological and epidemiological properties. HBV 
genotypes, subgenotypes and mutations in specific regions of the HBV genome 
play an important role in the rates of HBeAg and HBcAg seroconversion, viremia 
levels, immune escape, emergence of mutants, pathogenesis of liver fibrosis, disease 
progression, response and resistance to antiviral therapy, in addition to being 
predictive of clinical outcomes3.
Genotype A is mainly found in the North America and Africa. Genotypes B and 
C are prevalent in Southeast Asia and the Far East. Genotype D is found worldwide, 
mainly in the Mediterranean and Central Asia. Genotypes E and F are prevalent 
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in West Africa and among the indigenous peoples of the 
Americas, respectively. Genotype G has been reported in 
the United States, France, Colombia and Brazil. Genotype 
H has been shown to be prevalent in Central and North 
America. In addition, two new genotypes, I and J, have 
been recently reported in Vietnam, Laos, and Japan4-7. In 
Latin America, the presence of genotypes F and H is related 
to indigenous origins, and genotypes A and D result from 
the mixture between European and African populations8.
Overall, genotype A is the most prevalent in Brazil, 
followed by genotypes D and F. However, genotypes B 
and C have also been detected in some individuals9. Even 
though Brazil is as a country with intermediate hepatitis 
B endemicity, there is a large heterogeneity between 
Brazilian regions. Some studies show that across South 
and Southeast of Brazil, less than 2% of the population is 
infected with HBV. Towards the North of the country the 
incidence increases, and thus the Amazon basin presents a 
high prevalence of HBV infection10.
Epidemiological data11 shows that, among the different 
etiological agents of viral hepatitis, hepatitis B is the 
second most prevalent in Roraima. According to the 
National Immunization Program12, even though Roraima 
is considered an endemic region and the HBV vaccine is 
available for all age groups, coverage did not reach the 
goal stipulated by the Brazilian Ministry of Health in the 
following age groups: less than 1 year with 88.87%, 3 years 
94.34%, 15 to 19 years 88.92%, 20 to 24 years 62.69% and 
25 to 29 years 61.74%. 
Valaydon et al.13 associated mutations in gene S with 
resistance to vaccine; however, the correlation between 
HBV genotypes, possible mutants and escape from 
vaccination is still unknown. Studies suggest that the 
infection with HBV in vaccinated children was related to a 
wild type of the genotype E14 or to the genotypes B and C15.
The present study aims to characterize different HBV 
subgenotypes circulating in Roraima State, an important 
epidemiological issue, especially in a border area. Thus, 
our data will probably contribute to a better understanding 
of HBV genotypes and subgenotypes dispersion in the 
Northernmost region of Brazil.
METHODS
Roraima State is located in the Amazon region 
(Figure 1). It is the Northernmost and least populated 
State of Brazil. It is bordered to the East by the State of 
Para and Guyana, to the South and West by the State of 
Figure 1 - Geographic localization of Roraima State, Brazil
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Amazonas, and to the North by Venezuela. Roraima has 
15 municipalities, including the State capital, Boa Vista, 
where 63.53% of the State’s population is concentrated16.
In the study period, from 2013 to 2015, the prevalence 
rate of Hepatitis B was 13.9 per 100,000 habitants in 2013; 
16.5 in 2014 and 9.29 in 2015. The number of samples 
in this study represents 20.3% of the total of 197 chronic 
Hepatitis B patients registered in SINAN (Sistema de 
Informação de Agravos de Notificação) during this period12.
This analysis included whole blood samples collected 
from 113 patients with chronic Hepatitis B, defined as the 
persistence of the HBsAg for at least 6 months, associated 
with the presence of total anti-HBc and non-reagent anti-
HBc IgM. The number of samples analyzed accounts for 
71.97% of the total number of patients on therapy during 
the entire studied period. Samples were collected at the 
Central Laboratory of Roraima State (LACEN/RR) between 
January 2013 and March 2016, during a blood test to assess 
viral load. HBsAg-positive individuals of both genders aged 
18 years or more were enrolled in this study. Subjects signed 
an informed consent form prior to sample collection. This 
study was approved by the Research Ethics Committee of 
the Federal University of Roraima (Protocol Nº 121005) 
on October 26, 2012.
Genomic DNA of each sample was extracted from 
200 µl of whole blood using the QIAamp DNA Blood kit 
(Qiagen, USA) according to the manufacturer’s instructions. 
HBV DNA amplification was performed by a nested 
PCR using type-specific primers for the target region. 
The first-round PCR primers amplify a 447 bp fragment 
of the S region with primers FHBS1 (position 244 to 
267; 5’-GAGTCTAGACTCGTGGTGGACTTC-3’), and 
RHBS1 (position 688 to 691; 5’ GCTAAATKGCACTAG 
TAAACTGAGCCA-3’), and the second-round primers 
amplify a 417-bp fragment with primers FHBS2 (position 
255 to 278; 5’-CGTGGTGGACTTCTCTCAATTTTC-3’) 
and RHBS2 (position 648 to 671; 5’-GCCARGAGAAAC
GGRCTGAGGCCC-3’). PCR amplification was carried 
out (unpublished data). 
The positive samples were further purified with 
polyethylene glycol (PEG) at a final concentration of 20% 
according to the protocol used in the genomic platform of 
the Leonidas and Maria Deane Institute (ILMD), FIOCRUZ 
unit in Manaus, Amazonas. Samples were sequenced 
with BigDye® Terminator V3.1 Cycle Sequencing Kit 
(Applied Biosystem, Thermo Fisher Scientific, USA). 
The sequencing reaction was analyzed on an ABI 3130 
automated sequencer (Applied Biosystems, Thermo Fisher 
Scientific, USA). The quality of each electropherogram 
and assembly of the consensus sequence was performed 
using the Geneious-R6® software. Sequence identity was 
estimated using the BLASTn tool and compared with other 
HBV genomic sequences available at public databases. 
Sequences were genotyped by phylogenetic reconstruction 
using reference sequences from each HBV genotype 
obtained from GenBank (130 in total), comprising 280 bp of 
the partial S gene sequence. Bayesian phylogenetic analysis 
was conducted using the MCMC method implemented in 
MrBayes 3.1.2, using the nucleotide substitution model 
(GTR + G), as previously estimated in jModelTest v2.1.3. 
Fifteen million generations were enough to reach the 
convergence. A non-human primate external sequence was 
used as an external group to root the phylogenetic tree. The 
maximum clade credibility (MCC) tree was obtained by 
summarizing 15,000 trees and was then modified using a 
10% burn-in. Effective sample sizes >200, for all estimated 
parameters, were obtained after analysis with Tracer v.1.5. 
The resulting phylogenetic tree was visualized in FigTree 
v1.3.1. Sequences were deposited into the GenBank under 
the following accession numbers: KY780240 - KY780279.
RESULTS
In this study, the HBV DNA was found in 40 
patients (35.40%). Gender, age, demographical, virology 
information, genotype and subgenotype of these patients 
are presented in Table 1.
The age average of the patients was 39.6 ± 13.7 SD 
years, with 21 women and 19 men (X2 = 0.22, p = 0.6394). 
Of the total number of individuals analyzed in the study, 37 
declared their ethnicity with a majority of 59.4% declaring 
to be of mixed ethnicity (mixture of white and black) 
(X2 = 31.75, p <0.0001).
Of the 33 patients who declared their place of birth, 
25.8% reported having been born in Boa Vista, capital of 
the State of Roraima (X2 = 9.645, p = 0.0218). Only one 
individual claimed to have been born in Guyana, but he has 
lived in Brazil for more than 20 years. Most patients, 67.5%, 
lived in the capital Boa Vista (X2 = 4.90, p = 0.0269). All 
the individuals presented detectable viral load, with 50% 
of them with viral load above 2,000 IU/mL.
When we analyzed the genotypes (Figure 2), we found 
a higher frequency of genotype A, corresponding to 70% 
of the analyzed samples (X2 = 25.55, p <0.0001). For the 
subgenotypes, A1 was the most frequent one (X2 = 71.30, 
p < 0.0001), representing 60% of the samples, followed 
by subgenotypes A2 = 10%, D2 = 2.5%, D3 = 2.5 %, 
D4 = 2.5%, F2a = 12.5%, F3 = 10%.
A1 genotype was more prevalent among the group 
with mixed ethnicity (X² = 9,364, p = 0.0093); genotype 
A2 and F2a were equivalent in those with mixed ethnicity 
and Caucasians; D1 and D4 were reported only in those 
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“Asian-American” clade with isolates from Asia, Somalia, 
Caribbean islands and a restricted number of strains from 
South America17. Phylogenetic analysis of the subgenotype 
A1 indicated a posterior probability value of 1, splitting the 
“African” and “Asian-American” clades. In the “African” 
clade, strains were grouped into clusters previously isolated 
in Brazil, Cameroon, Gambia and Nigeria. The “Asian-
American” clade clustered a larger number of analyzed 
strains, together with isolates from Brazil, Rwanda, Kenya, 
Colombia, Belgium and Martinique.
DISCUSSION
This study reports the geographic distribution of 
HBV genotypes in the Brazilian State of Roraima. 
Molecular characterization of HBV isolates is invaluable 
in establishing HBV evolutionary origins and dispersion 
patterns18. Molecular evolutionary studies to characterize 
HBV in Roraima have an even more vital role, once this 
State shares international land borders with Venezuela 
and British Guyana, countries where hepatitis B is highly 
endemic. The distribution of HBV genotypes varies 
across different geographical regions, some are distributed 
worldwide, whereas others are more geographically 
confined19.
The results of genotyping are in agreement with previous 
records found in Brazil, showing that genotype A prevails 
(28/40 - 70%), followed by genotypes F (9/40 - 22.5%) and 
D (3/40 - 7.5%); (X2 = 25.55, p < 0.0001)20-23. Recently, 
a study involving samples of HBV representing the five 
Brazilian regions showed that the genotypes A, D and F are 
the main genotypes found in the country24. The distribution 
of genotypes in the Brazilian population is correlated with 
its heterogeneous ethnic origin25, which is an admixture of 
European, Native American and African ancestors6.
Genotype A is subdivided into subgenotypes A1 to A7. 
Among them, A1 is highly prevalent in sub-Saharan Africa 
and Northern Europe; subgenotype A2 and A3 are prevalent 
in Western Africa; A4 and A5 were found in sub-Saharan 
Africa (Mali, Gambia, Nigeria); A5 was found in people 
of African descent in Haiti26,27.
In Northern Brazil, genotype A,mainly the subgenotype 
A1, is predominant and was probably introduced in Brazil 
during the slave trade28,29. A study carried out in the Western 
Brazilian Amazon at Labrea municipality, Amazonas State, 
identified the presence of genotypes A (60%), D (35%) 
and F (5%)22. Another study on HBsAg-positive blood 
performed in Manaus, Amazon Region, Northern Brazil, 
showed a high prevalence of genotype A, as well as the 
predominance of HBV genotypes A and F20.
Previous studies have shown that only two subgenotypes 
Table 1 – Characteristics of the 40 chronic hepatitis B patients 
included in this study
Parameters P- value*
Patients 40
Age (average±SD) 39,62(±13,74 )
Gender [n(%)]
     Male 19(47,5)  NSa
     Female 21(52,5)
Race [n(%)]
     White 7(18,9)
     Mixed ethnicity 22(59,4) < 0.0001a
     Black 4(10,8)
     Indigenous 4(10,8)
     Not informed 3
Residence place[n(%)]
     Boa Vista (capital) 26(67,5) = 0.0269a
     Another Roraima’s 
     municipality
14(32,5)
Birth place [n(%)]
     Boa Vista (capital) 8(25,8)
     Another Roraima’s 
     municipality
10(29) = 0.0218a
     Another Brazil’s state 15(41,9)
Viral load  (UI/mL) [n(%)]
     > 2000 20 (50) NSa
     < 2000 20 (50)
Genotypes [n(%)]
     A 28(70) < 0.0001a
     D 3(7,5)
     F 9(22,5)
Subgenotypes [n(%)]
     A1 24(60) < 0.0001a
     A2 4(10)
     D2 1(2,5)
     D3 1(2,5)
     D4 1(2,5)
     F2a 5(12,5)
     F3 4(10)
a: Teste X2; p>0,05; NS- not significant; SD – standard deviation
with mixed ethnicity , D2 only in blacks and F3 only in 
the indigenous group.
Phylogenetic tree reconstructions (Figure 2) showed 
two distinct clades inside the subgenotype A1. One 
clade is predominantly “African” and includes isolates 
from South, East and Central Africa, and the other is an 
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of genotype A (A1 and A2) have been found in Brazil, where 
HBV/A1 has been the sole or most prevalent one18,21,23,30. 
Our results corroborated a phylogenetic study with isolates 
from different regions of Brazil, which showed that two 
distinct clades have been recognized into subgenotype A131. 
However, unlike our findings, Brazilian strains grouped into 
the “Asian-American” clade only.
Similar results of the split between “African” and 
“Asian-American” clades were also found in a study carried 
out in Martinique, which identified most of the sequences as 
belonging to the “Asian-American” clade17. The findings in 
our study are probably due to the presence of a highly mixed-
race population in Roraima, which consists of descendants 
from different geographic regions in Brazil and abroad. 
Also, the sequences in these two clusters did not form a 
single clade in the tree and few sequences clustered with 
other Brazilian sequences described above, indicating these 
viruses were probably introduced into the State at different 
moments. These results are similar to those of previous 
studies carried out in the Brazilian States of Rondonia18 
and Rio de Janeiro32, which found a large number of HBV 
isolates belonging to subgenotype A1. Recently, another 
study performed in Para found the genotypes A and F as the 
predominant ones in these populations. Genotype A was the 
most frequentwith 88.46%, and among the subgenotypes, 
AI represented 78.26%, followed by A2 21.74% and the 
prevalence of genotype F was 11.54%33.
In contrast, few sequences in this study were grouped 
into subgenotype A2, classified as European, which was 
supposedly introduced in Europe by Portuguese sailors 
traveling along the coastal waters of South Africa during the 
15th, 16th and 17th centuries. Some authors have speculated 
Figure 2 - Phylogenetic analysis of HBV strains isolated in Roraima. The maximum clade credibility (MCC) tree was estimated by 
Bayesian analysis of 130 sequences according to the S region (280 bp). The posterior probabilities of the key nodes are shown 
above according to the respective nodes. HBV isolates from Roraima are represented in red and were analyzed together with 
other worldwide stains.
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that subgenotype A2 has evolved from a subgroup of A1 
isolates34. This result corroborates previous findings that 
showed low prevalence or inexistence of genotype A2 in 
the North and Northeast regions4,18,20. This subgenotype is 
found in Europe, the United States, England, Argentina, 
Colombia and Spain19. Considering the geographic 
distribution of the two subgenotypes (A1 in Africa and A2 in 
Europe), the prevalence of A2 in Southern Brazil correlates 
with the European origin of the population31.
Only three sequences were grouped into genotype 
D, presenting low prevalence (3/40 - 7.5%). Our study 
confirms the low prevalence or absence of genotype D 
found in the North and Northeast regions20,35. In contrast, a 
study carried out among HBV chronically infected patients 
in the State of Rondonia, Northern Brazil, detected a 
prevalence of 42.8%18. Another recent study, performed in 
the State of Maranhao, located in the Brazilian Northwest 
region, showed that genotype D was the most frequent 
one (84%; 42/50)36. Lampe et al.24 showed that among the 
five Brazilian regions, genotype D is the most prevalent 
only in the South of Brazil, representing 80% (75/95) of 
the analyzed samples in that area. Previous studies have 
indicated that genotype D is more frequent in the Southern 
Brazilian populations, due to their prevalent European 
ancestry resulting from the massive migration of 1872-1975. 
The spread of genotype D strains in the Amazon basin is 
probably due to the presence of migrants from South and 
Southeast Brazil, where genotype D is widespread23,25.
Within genotype D, four subgenotypes can be found: D1 
occurs mostly in the Mediterranean and Middle East; D2 has 
been reported in India, Japan, Europe, and the United States; 
D3 has been registered in South Africa, Brazil, Rwanda, 
Costa Rica and the United States and D4 in Australia, South 
Africa, Somalia, Rwanda and Oceania19.
The phylogenetic tree showed three D strains 
subgenotypes: D2, D3 and D4. These subgenotypes were 
also found in previous studies carried out in the Amazon 
States of Amazonas30 and Rondonia18, and in the Northeast 
State of Maranhao21. The sequence of subgenotype D4, 
isolated in the State of Roraima, formed a clade more 
closely related to strains previously isolated in the States of 
Rondonia18 and Maranhao21 and also a sequence similar to 
a Venezuelan strain37, an HBV endemic country bordering 
Roraima, suggesting that these international borders may 
become the entry of new HBV genotypes into the country.
The sample designated subgenotype D2 formed a closer 
group with previously isolated sequences in Japan and 
Brazil. HBV subgenotype D2 was previously described as 
prevalent in the South and Central-West regions of Brazil23, 
and it may have probably been introduced to Roraima by 
immigrants from those regions. The HBV subgenotype D3 
strain was closely related to a Colombian isolate, forming 
a monophyletic group and exhibiting a genetic distance 
from other previously described Brazilian sequences. This 
result suggests that the presence of Colombian immigrants 
in the State might have introduced a different HBV strain 
into the country. HBV subgenotype D3 is more frequently 
found in the North and Central-West regions of Brazil23. 
Due to the small number of representative sequences for 
each subgenotype of genotype D found in our study, further 
studies will be required to confirm these observations.
Genotype F is indigenous to the Americas, therefore 
is the most prevalent HBV genotype among Amerindians 
of the Amazon basin and Central and South America18. In 
addition, previous studies have indicated that genotype F 
is indeed the oldest genotype circulating in the Americas28. 
This genotype is highly prevalent in Venezuela38, a region 
inhabited by Amerindian populations, supporting the 
hypothesis that genotype F is inherent in these groups. 
Genotype F is classified into four subgenotypes (F1-
F4) which are further subdivided into different clades. 
Subgenotype F1, which splits into F1a and F1b, is highly 
prevalent in Central America, Alaska and Southeast 
America; F2 (F2a and F2b) is highly prevalent in Venezuela, 
and is also found in Brazil (clade F2a only); F3 is present 
in Central America (Panama) and Northern Latin America 
(Colombia and Venezuela), and is also present in Brazil 
according to our results and F4 is present in Bolivia and 
Argentina39.
Unlike other Latin American countries, where genotype 
F prevails, Brazil shows a low countrywide prevalence of 
HBV/F (13%), suggesting that indigenous people are less 
influential in introducing HBV into the country9,23. This 
genotype has been frequently reported in the Brazilian 
Amazon, especially among native populations9,18,20. Castilho 
et al.35 reported a high prevalence of genotype F in three 
riverside communities of Labrea municipality, Amazonas 
State, Brazil. Another study conducted in the Brazilian 
Amazon Basin showed the prevalence of genotype F in 
50% of the patients who developed fulminant hepatitis B 
and died30. Nevertheless, these results show a low frequency 
of genotype F (9/40; 22.5%), as observed in most studies 
conducted across different Brazilian regions, including 
the Amazon basin9,18,21,22. This low frequency in our study 
can be probably explained by the lower representation of 
indigenous subjects in our sample, the high miscegenation 
in Roraima, and the contact between indigenous and non-
indigenous people.
Subgenotype F2a was prevalent where the sequences 
formed a clade with Venezuelan strains and other previously 
described Brazilian sequences. This result was corroborated 
by Mello et al.28 who argued that subgenotype F2a is 
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prevalent countrywide, being found in all geographic 
regions of Brazil. In addition, HBV/F2a is found almost 
exclusively in Brazil and Venezuela, with the exception of 
one HBV/F2a sequence isolated in Nicaragua. By using a 
phylogeographical approach, the authors also concluded 
that this subgenotype probably originated in Venezuela 
and reached Brazil following a North-to-South viral flow. 
This corroborates that Roraima is a major point of entry for 
several pathogens into the country. Furthermore, our data 
are also similar to previous studies carried out in Brazil 
showing the same phylogenetic pattern for the circulation 
of subgenotype F2a18,21,23,28. In addition, the analyzed 
strains did not form a homogeneous clade within the F2a 
subgenotype, suggesting different moments of virus entry 
into the State. This hypothesis is supported by the intense 
influx of people on the Brazilian-Venezuelan border, and 
especially the current increased Venezuelan immigration 
in Brazil, mainly towards the border State of Roraima, 
which might probably spread different HBV/F2a strains 
in the region. 
HBV/F3 was the second most frequent subgenotype 
within genotype F. This work shows for the first time 
subgenotype F3 isolates found in Brazil. Subgenotype 
HBV/F3 is highly prevalent in the general population of 
Venezuela and Colombia4,40, and has also been found in 
Panama41. In addition, previous studies have identified 
the HBV/F3 subgenotype circulating among indigenous 
peoples of Venezuela (Yukpa, Warao, Piaroa, Yanomami)40. 
The four HBV/F3 isolates in our study were detected among 
members of indigenous people living in the Brazilian-
Venezuelan borders (a region comprising part of Roraima 
and Amazonas). Our phylogenetic analysis showed that 
those sequences were clustered in different clades. Two of 
the sequences formed a monophyletic clade with another 
strain previously isolated from members of the Yanomami 
in Venezuela (DQ899148)40, indicating that these strains 
probably co-circulate in this population, perhaps due 
to migration between neighboring communities. Other 
sequences revealing two distinct clusters have a genetic 
pattern similar to the previously isolated sequences in 
Colombia and are likely representative of the general 
population. A possible explanation for this greater genetic 
similarity is that these strains may have been introduced 
in Roraima at the Colombia/Amazonas border, thereby 
reaching the community and spreading throughout this 
territory. Since the F3 isolates described in our study come 
from self-identified indigenous individuals, we can infer 
that different strains of this subgenotype are likely to co-
circulate exclusively in these communities. However, due to 
the few sequences of subgenotype F3 isolated in our study, 
further analysis is required to support these conclusions.
 As our number of samples is low, we cannot perform more 
correlation studies,however, we believe on the importance 
of the genotypic characterization and its relationship with 
ethnicity, since these data will be able to supply us with a 
better understanding of the association between health data of 
the general population and their relationship with genotypes 
and subgenotypes, especially in this area of the country, 
which is influenced by its geographical location next to the 
Caribbean and bordering countries.
CONCLUSIONS
In this study, we performed a molecular characterization 
of HBV strains derived from HBV-DNA-positive patients 
living in the Brazilian State of Roraima. The frequency and 
distribution of the genotypes were similar to those found 
in different geographical regions of Brazil. We have shown 
that “Asian-American” HBV/A1 is the main circulating 
subgenotype. HBV subgenotypes A2, D2, D3, D4, F2a 
were also detected, and F3 was first recorded in Brazil. 
These findings underscore the importance of continuous 
molecular epidemiological surveillance at a local level in 
order to provide a better understanding of the virus behavior 
patterns and tools to better target this disease.
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